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Abstract
Most metazoan miRNAs (microRNAs) bind to sites in the 3′-UTRs (untranslated regions) of mRNA targets
and negatively regulate protein synthesis. The liver-specific miR-122, however, exerts a positive effect on
HCV (hepatitis C virus) RNA levels by binding directly to a site in the 5′-UTR of the viral RNA. HCV translation
and RNA stability are unaffected, and therefore miR-122 is likely to act at the level of viral replication. The
miR-122-binding site in HCV RNA was examined to determine whether the nature of the site is responsible
for the unusual mode of action for a miRNA. When the site was placed in the 3′-UTR of a reporter mRNA,
miR-122 repressed translation, and therefore the location of the miR-122-binding site dictates its effect
on gene expression. Additionally, a second binding site for miR-122 was identified in the HCV 5′-UTR, and
miR-122 binding to both sites in the same viral RNA was found to be necessary for viral replication. The two
sites are adjacent and are separated by a short spacer, which is largely conserved between HCV genotypes.
The binding site requirements for miR-122 to positively regulate HCV replication provide an insight into this
unusual mode of miRNA action.
Introduction
miRNAs (microRNAs) are non-coding RNAs expressed by
a wide range of eukaryotic organisms that are important in
the control of gene expression [1]. Several hundred miRNAs
are expressed in mammals, initially as part of large precursor
transcripts, which subsequently undergo nuclear and cyto-
plasmic processing to yield 21–23 nt single-stranded mature
miRNA molecules. miRNAs can mediate cleavage of exactly
complementary RNA targets, but in metazoan systems most
miRNAs have been shown to function by binding with
imperfect complementarity to 3′-UTR (untranslated region)
sites as part of a complex of proteins known as the miRNP.
This binding resulted in inhibition of gene expression, which
occurred at the level of translation initiation or by a post-
initiation block in different studies. Localization of mRNA
to processing (P) bodies and subsequent degradation has also
been observed, and it is likely that all three mechanisms of
repression may function in different circumstances [2].
In higher organisms miRNAs show a high degree of
specificity of expression, both according to tissue type and
developmental stage. miR-122 was identified as a highly
liver-specific miRNA and was found to account for approx.
70 % of total liver miRNA content, with approx. 66 000
copies per cell [3].
HCV (hepatitis C virus) is a hepatotropic positive-sense
RNA virus that establishes persistent infections in liver tissue
[4]. Infection can eventually lead to cirrhosis of the liver
and hepatocellular carcinoma. Current antiviral therapies are
frequently ineffective, and a greater understanding of the
virus is important for the development of new treatments. We
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examined liver cell lines and found that miR-122 is expressed
in Huh7 cells, which are supportive of HCV replication, but
not in a different human liver cell line, HepG2 [5]. Huh7
cells stably expressing a dicistronic HCV replicon, in which
the EMCV (encephalomyocarditis virus) IRES (internal
ribosome entry site) directs translation of the complete HCV
polyprotein, whereas HCV 5′- and 3′-UTRs allow replication
to occur [6], were also examined, and miR-122 was expressed
in these cells. We were interested to see what impact the
presence of high levels of miR-122 had on HCV replication,
and used a 2′-O-methylated antisense oligonucleotide to
sequester miR-122 in Huh7 cells. Both in Huh7 cells stably
containing the dicistronic genotype 1b HCV replicon de-
scribed above, and in cells transiently expressing a full-length
type 1a HCV replicating RNA [7], sequestration of miR-122
resulted in a dramatic reduction in HCV RNA levels [5].
Mutagenesis indicated that miR-122 binds to a site in the
5′-UTR of HCV RNA and that its effect on HCV is due
to this binding. The miR-122–binding site we identified is
in an unstructured region of the 5′-UTR, upstream of the
HCV IRES, and is conserved across all six genotypes of
the virus (Figure 1A, seed match 1). We observed no effect
of miR-122 binding on HCV translation or RNA stability,
and concluded that miR-122 positively regulates HCV at the
level of viral replication [5].
The miR-122-binding site from HCV
mediates repression of gene expression
when placed in a heterologous 3′-UTR
The discovery of this novel mode of action for a miRNA
suggested that particular features of miR-122 or its binding
site in HCV might cause this unusual mode of regulation.
A major determinant of productive miRNA binding has
been found to be exact Watson–Crick complementarity to
nt 2–7 of the miRNA, known as the ‘seed’. This seed match
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Figure 1 miR-122 binds to two adjacent sites in the 5′-UTR of
HCV RNA
(A) Sequence conservation of the region spanning the two miR-122
seed matches across genotypes of HCV. Nucleotides forming the seed
matches are shown in capitals, and conserved nucleotides in bold. The
numbers indicate the position of this sequence relative to the 5′-end
of each HCV isolate. The isolates shown are H77c (type 1a), HCV-N
(1b), JFH-1 (2a), NZL1 (3a), HEMA51 (4a), FRT41 (5a) and TH271 (6f).
(B) Model for concurrent binding of two miR-122 molecules to the
adjacent binding sites in the HCV 5′-UTR.
should ideally be flanked by A residues pairing to nt 1 and
8 of the miRNA [8]. Further pairing to the 3′ region of the
miRNA contributes to binding affinity, but is less crucial.
The miR-122-binding site in HCV fits this model (Figure 1B,
seed match 1), despite the fact that miR-122 binding to this
site does not lead to repression of HCV translation [5].
The region spanning the miR-122-binding site was
amplified from the HCV 5′-UTR by PCR, and inserted in
the 3′-UTR of the firefly luciferase gene. Transfection of this
firefly luciferase plasmid into Huh7 cells and sequestration
of miR-122 showed that miR-122 mediates repression of
luciferase expression from this mRNA, and quantitative RT
(reverse transcriptase)–PCR indicated that luciferase mRNA
levels are unaffected, so repression occurs at the level of
translation [9]. Mutagenesis of the miR-122-binding site, and
introduction of mutant miR-122 that can bind to the mutant
site, showed that the miR-122 response is partly mediated
by binding to this site. However, some miR-122-dependent
down-regulation of luciferase expression persisted when
the site was mutated. A second miR-122 seed match exists
adjacent to, and downstream of, the first one. This seed
match (seed match 2) extends from nt 2 to 7 of miR-122
and lacks the A residues pairing to positions 1 and 8
that are seen in seed match 1 (Figure 1B). However, this
second seed match is conserved across HCV genotypes
(Figure 1A, seed match 2), suggesting a possible functional
role. Mutagenesis of both seed matches in the 3′-UTR of
luciferase abolished miR-122-dependent repression of luci-
ferase expression, which was restored by introduction of
mutant miR-122 that binds to the mutant site [9]. This
indicated that miR-122 mediates repression of gene expres-
sion via both these adjacent sites in the context of a 3′-UTR.
miR-122 regulates HCV replication via two
adjacent binding sites
These findings raised the question as to whether miR-122
binds to both adjacent seed matches in the context of HCV
RNA. Point mutations were introduced into the miR-122
seed match 2 in a plasmid encoding an HCV type 1a (H77)
genomic RNA, containing five adaptive mutations that
allow efficient replication in Huh7 cells [7]. Following the
introduction of the mutant RNA into cells and a five-day
culture period to allow replication to occur, no HCV RNA
was detectable. Moreover, the introduction of a miR-122
mutant that can bind to this mutant site led to the restoration
of HCV RNA levels, indicating that miR-122 binding
to this second site is necessary for HCV replication to
occur. Levels of HCV RNA containing mutations in both
miR-122-binding sites could also be restored by transfection
of mutant miR-122 molecules that can bind to the sites.
Importantly, when different mutations were introduced
into each of the two sites, individual miR-122 mutants that
could bind to both sites had to be introduced into cells in
combination for HCV replication to occur. This indicates
that miR-122 must bind to both sites within the same HCV
molecule [9]. However, it is not yet known whether this is
due to a requirement for overlapping binding to the two sites
(Figure 1B), or for a sequential binding process.
Multiple binding sites for the same or different miRNAs
are frequently observed in 3′-UTRs, and some co-operativity
occurs when miRNAs bind to adjacent sites, with an optimal
distance of 13–35 nt between the start of two seed matches
[10]. However, the essential requirement for binding to the
two adjacent miR-122 seed matches that we find in HCV
RNA has not been observed in other systems. An additive,
but inessential, effect of multiple copies of the miR-122-
binding site from HCV was observed in the context of the
3′-UTR of luciferase mRNA, indicating that the absolute
requirement for the double binding site is specific to HCV
replication. The sites are separated by an 8 nt spacer that
is largely conserved across HCV genotypes (Figure 1A),
and preliminary data indicate that the length and sequence
of the spacer are important for HCV replication [9]. It is
possible that miR-122 binding to the adjacent sites allows the
recruitment of an oligomeric protein complex to the 5′-UTR
of HCV and that this is required for viral replication.
Implications for miRNA function
The finding that a miRNA can bind to the same site in
different contexts and mediate different events suggests that
miRNA activity is more flexible than was previously thought.
Most efforts, both experimental and computational, to detect
miRNA-binding sites have been directed towards the 3′-
UTR. Several recent studies, however, suggest that miRNA
activity may extend beyond repression of gene expression via
3′-UTR sites. It was shown that miR-369-3 binds to AU-rich
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elements in the 3′-UTR of the TNFα (tumour necrosis factor
α) mRNA and mediates a switch from repression to activation
of mRNA translation upon serum starvation. Similar effects
were observed with a let-7 target, and recruitment of the
FXR1 (fragile X mental retardation-related protein 1) protein
as part of the miRNP was responsible for this change in
activity [11]. Further study is needed to indicate how general
a mechanism this is, but it provides an indication that the
cellular environment and the composition of the miRNP
may have a considerable effect on miRNA activity.
Very recently, miR-10a was shown to interact with sites
in the 5′-UTR of 5′-TOP (5′-terminal oligopyrimidine tract)
mRNAs [12]. These mRNAs encode components of the
ribosome and translational machinery. The TOP sequence
at the 5′-end of these mRNAs governs a rapid increase
in translation in response to growth signals. miR-10a was
shown to bind downstream of, and adjacent to, the TOP
sequence, and this binding was required for activation of
translation. Interestingly, the binding sites for miR-10a in
TOP mRNAs did not have extensive seed matches, although
the overall thermal stability of the miRNA–mRNA duplex
was good. Other target sites that are similar to this, and
may not be present in 3′-UTRs, are likely to have been
missed by current bioinformatic site identification tools. As
with miR-122, miR-10a can mediate different processes by
binding to sites in different locations, as 3′-UTR-binding
sites for this miRNA were also identified, and miR-10a
binding to these sites results in repression of gene expression.
The mechanism by which miR-10a positively regulates
translation of TOP mRNAs is not yet known.
The miRNA pathway and viruses
The role for miR-122 in HCV replication fits in with
increasing evidence of interplay between viral infection and
the miRNA pathway. Several DNA viruses express miRNAs,
and these can regulate both viral and cellular transcripts and
play a role in viral infection or latency. Other studies have
suggested that cellular miRNAs directly target and repress
PFV-1 (primate foamy virus 1) and VSV (vesicular-stomatitis
virus), but the role of these miRNAs in viral infection has not
been established, and it is likely that viruses would evolve
to escape deleterious host miRNA interactions [13]. As yet,
a positive effect on viral replication by direct binding of a
cellular miRNA has only been observed in HCV, but it is
possible that this mechanism may extend to different viruses.
A recent paper showed that IFN (interferon) β treatment
of cells results in up-regulation of a number of miRNAs
[14]. Five of these have predicted targets in the HCV RNA
genome, and their overexpression exerts a negative effect
on HCV. Mutagenesis indicated that direct binding to their
sites in HCV RNA mediates this effect for two of these
miRNAs. Interestingly, miR-122 expression decreased upon
IFN treatment, and overexpression of miR-122 partially
alleviated the antiviral effects of IFN [14].
Further research has indicated that miR-122 is required
for HCV replication in the genotype 2a JFH-1 system,
which permits production of infectious virus in Huh7 cells.
Therefore, it appears that the conservation of the miR-
122-binding sites across genotypes of HCV is functionally
important and that the miR-122 requirement for HCV
replication extends across genotypes. Moreover, RNAi (RNA
interference)-mediated knockdown of components of the
miRNA and RNAi pathways resulted in inhibition of HCV
replication [15]. This indicates that the positive effect of
miR-122 on HCV replication overrides the effects of any
negatively acting miRNAs or siRNAs.
The finding that a miRNA is required for HCV infection
has great potential for the development of novel antiviral
therapies. Excitingly, intravenous injection of LNA (locked
nucleic acid)-modified oligonucleotides complementary
to miR-122 into African green monkeys led to effective,
reversible inhibition of miR-122 activity in the liver [16]. The
relief of miR-122 inhibition of cellular targets, most of which
are involved in cholesterol metabolism, resulted in a decrease
in total plasma cholesterol levels. No toxicity was observed
over the course of the study, suggesting that targeting miR-
122 is a promising avenue to pursue for the treatment of HCV
infection. A greater understanding of the role for miR-122
binding to the two adjacent sites we have identified in HCV
is important for the future development of novel therapies.
References
1 Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and
function. Cell 116, 281–297
2 Standart, N. and Jackson, R.J. (2007) MicroRNAs repress translation
of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and
promoting deadenylation. Genes Dev. 21, 1975–1982
3 Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M.A.,
Xu, C., Mason, W.S., Moloshok, T., Bort, R. et al. (2004) miR-122, a
mammalian liver-specific microRNA, is processed from hcr mRNA and
may downregulate the high affinity cationic amino acid transporter
CAT-1. RNA Biol. 1, 106–113
4 Hoofnagle, J.H. (2002) Course and outcome of hepatitis C. Hepatology 36
(Suppl. 1), S21–S29
5 Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M. and Sarnow, P. (2005)
Modulation of hepatitis C virus RNA abundance by a liver-specific
microRNA. Science 309, 1577–1581
6 Ikeda, M., Yi, M., Li, K. and Lemon, S.M. (2002) Selectable subgenomic
and genome-length dicistronic RNAs derived from an infectious
molecular clone of the HCV-N strain of hepatitis C virus replicate
efficiently in cultured Huh7 cells. J. Virol. 76, 2997–3006
7 Yi, M. and Lemon, S.M. (2004) Adaptive mutations producing efficient
replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells.
J. Virol. 78, 7904–7915
8 Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing,
often flanked by adenosines, indicates that thousands of human genes
are microRNA targets. Cell 120, 15–20
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